131 related articles for article (PubMed ID: 19675187)
1. Bovine papillomavirus type 1 oncoprotein E5 inhibits equine MHC class I and interacts with equine MHC I heavy chain.
Marchetti B; Gault EA; Cortese MS; Yuan Z; Ellis SA; Nasir L; Campo MS
J Gen Virol; 2009 Dec; 90(Pt 12):2865-2870. PubMed ID: 19675187
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of MHC class I by bovine papillomavirus E5 oncoproteins.
Ashrafi GH; Tsirimonaki E; Marchetti B; O'Brien PM; Sibbet GJ; Andrew L; Campo MS
Oncogene; 2002 Jan; 21(2):248-59. PubMed ID: 11803468
[TBL] [Abstract][Full Text] [Related]
3. The bovine papillomavirus oncoprotein E5 retains MHC class I molecules in the Golgi apparatus and prevents their transport to the cell surface.
Marchetti B; Ashrafi GH; Tsirimonaki E; O'Brien PM; Campo MS
Oncogene; 2002 Nov; 21(51):7808-16. PubMed ID: 12420217
[TBL] [Abstract][Full Text] [Related]
4. The E5 protein of BPV-4 interacts with the heavy chain of MHC class I and irreversibly retains the MHC complex in the Golgi apparatus.
Marchetti B; Ashrafi GH; Dornan ES; Araibi EH; Ellis SA; Campo MS
Oncogene; 2006 Apr; 25(15):2254-63. PubMed ID: 16288210
[TBL] [Abstract][Full Text] [Related]
5. Different contribution of bovine papillomavirus type 1 oncoproteins to the transformation of equine fibroblasts.
Yuan Z; Gault EA; Campo MS; Nasir L
J Gen Virol; 2011 Apr; 92(Pt 4):773-83. PubMed ID: 21177927
[TBL] [Abstract][Full Text] [Related]
6. The E5 oncoprotein of BPV-4 does not interfere with the biosynthetic pathway of non-classical MHC class I.
Araibi EH; Marchetti B; Dornan ES; Ashrafi GH; Dobromylskyj M; Ellis SA; Campo MS
Virology; 2006 Sep; 353(1):174-83. PubMed ID: 16806386
[TBL] [Abstract][Full Text] [Related]
7. Association of bovine papillomavirus with the equine sarcoid.
Chambers G; Ellsmore VA; O'Brien PM; Reid SWJ; Love S; Campo MS; Nasir L
J Gen Virol; 2003 May; 84(Pt 5):1055-1062. PubMed ID: 12692268
[TBL] [Abstract][Full Text] [Related]
8. Expression of a transforming gene (E5) of bovine papillomavirus in sarcoids obtained from horses.
Carr EA; Théon AP; Madewell BR; Hitchcock ME; Schlegel R; Schiller JT
Am J Vet Res; 2001 Aug; 62(8):1212-7. PubMed ID: 11497440
[TBL] [Abstract][Full Text] [Related]
9. Establishment and characterization of equine fibroblast cell lines transformed in vivo and in vitro by BPV-1: model systems for equine sarcoids.
Yuan ZQ; Gault EA; Gobeil P; Nixon C; Campo MS; Nasir L
Virology; 2008 Apr; 373(2):352-61. PubMed ID: 18191170
[TBL] [Abstract][Full Text] [Related]
10. Golgi alkalinization by the papillomavirus E5 oncoprotein.
Schapiro F; Sparkowski J; Adduci A; Suprynowicz F; Schlegel R; Grinstein S
J Cell Biol; 2000 Jan; 148(2):305-15. PubMed ID: 10648563
[TBL] [Abstract][Full Text] [Related]
11. All 4 di-leucine motifs in the first hydrophobic domain of the E5 oncoprotein of human papillomavirus type 16 are essential for surface MHC class I downregulation activity and E5 endomembrane localization.
Cortese MS; Ashrafi GH; Campo MS
Int J Cancer; 2010 Apr; 126(7):1675-82. PubMed ID: 19876920
[TBL] [Abstract][Full Text] [Related]
12. Bovine papillomavirus load and mRNA expression, cell proliferation and p53 expression in four clinical types of equine sarcoid.
Bogaert L; Van Poucke M; De Baere C; Dewulf J; Peelman L; Ducatelle R; Gasthuys F; Martens A
J Gen Virol; 2007 Aug; 88(Pt 8):2155-2161. PubMed ID: 17622617
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of equine matrix metalloproteinase 1 by bovine papillomavirus type 1 is through the transcription factor activator protein-1.
Yuan Z; Gault EA; Campo MS; Nasir L
J Gen Virol; 2011 Nov; 92(Pt 11):2608-2619. PubMed ID: 21775582
[TBL] [Abstract][Full Text] [Related]
14. E5 protein of human papillomavirus type 16 selectively downregulates surface HLA class I.
Ashrafi GH; Haghshenas MR; Marchetti B; O'Brien PM; Campo MS
Int J Cancer; 2005 Jan; 113(2):276-83. PubMed ID: 15386416
[TBL] [Abstract][Full Text] [Related]
15. Sequence variants of bovine papillomavirus E5 detected in equine sarcoids.
Chambers G; Ellsmore VA; O'Brien PM; Reid SW; Love S; Campo MS; Nasir L
Virus Res; 2003 Oct; 96(1-2):141-5. PubMed ID: 12951274
[TBL] [Abstract][Full Text] [Related]
16. The serological detection of Bovine papillomavirus's E5 oncoprotein antibodies in horses.
Hoikhman R; Molinková D; Pillárová D; Linhart P; Kopecká A; Jahn P
Vet Immunol Immunopathol; 2023 Aug; 262():110633. PubMed ID: 37542957
[TBL] [Abstract][Full Text] [Related]
17. E5 nucleotide polymorphisms suggest quasispecies occurrence in BPV-1 sub-clinically infected horses.
Savini F; Gallina L; Prosperi A; Battilani M; Bettini G; Scagliarini A
Res Vet Sci; 2015 Oct; 102():80-2. PubMed ID: 26412524
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional changes induced by bovine papillomavirus type 1 in equine fibroblasts.
Yuan ZQ; Nicolson L; Marchetti B; Gault EA; Campo MS; Nasir L
J Virol; 2008 Jul; 82(13):6481-91. PubMed ID: 18434409
[TBL] [Abstract][Full Text] [Related]
19. Inoculation of young horses with bovine papillomavirus type 1 virions leads to early infection of PBMCs prior to pseudo-sarcoid formation.
Hartl B; Hainisch EK; Shafti-Keramat S; Kirnbauer R; Corteggio A; Borzacchiello G; Tober R; Kainzbauer C; Pratscher B; Brandt S
J Gen Virol; 2011 Oct; 92(Pt 10):2437-2445. PubMed ID: 21715602
[TBL] [Abstract][Full Text] [Related]
20. No evidence of bovine papillomavirus type 1 or 2 infection in healthy equids.
Pratscher B; Hainisch EK; Sykora S; Brandt S; Jindra C
Equine Vet J; 2019 Sep; 51(5):612-616. PubMed ID: 30560998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
